AnaCardio raised $19m in Series A funding from Novo, Pureos Bioventures, Sound Bioventures, Flerie Invest, Industrifonden, and angel investors in Sweden Health services Manufacturing Pharma Investments 30 December 2024 Share:
Round value (USD): 19m Round investors: Flerie Invest Industrifonden Novo A/S Pureos Bioventures Sound Bioventures Fredrik Ljungström Ann-Helene Ljungström Company: AnaCardio Industry: Health services Manufacturing Pharma
PharmNovo in a €15 million equity funding with EIC Fund, contingent upon securing equivalent funding from co-investors. Health services Pharma Investments 06 July 2024